While there is a big buzz around digital adoption by Indian Pharma, necessitated by the disruption brought about by Covid-19, it is also a good time to discuss the future of Indian Pharma market and how it is likely to shape up.
This article by Rajeev Kumar was published in the April 2018 issue of MedicinMan. It will be great to listen to the perspectives of Indian Pharma leaders. Do share your thoughts here about the challenges, opportunities and the future of Indian Pharma.
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
